Mednet Logo
HomeAllergy & Immunology
Allergy & Immunology

Allergy & Immunology

Expert discussions on allergic conditions, immunodeficiencies, drug hypersensitivity, and immunotherapy approaches.

Recent Discussions

Would you ever use dupilumab for atopic dermatitis in a patient who also has EGPA?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Harvard Medical School

I would consider it if AD was moderate to severe and not improving with TCS, TCI, or Opzelura. I would make sure the skin was biopsied to rule out a vasculitic component to the rash, as EGPA skin manifestations are varied.

How soon after stopping oral steroids can patch testing be performed?

1 Answers

Mednet Member
Mednet Member
Dermatology · Geisinger Commonwealth Medical College

Dose strength and duration of oral steroid therapy should factor into the equation. I would say at least 2 weeks to be on the less cautious side and up to 1 month if there is no urgency to patch test.

What role do you feel topical steroids play in the management of atopic dermatitis with the growing availability of non-steroid topicals?

1
1 Answers

Mednet Member
Mednet Member
Dermatology · University of Arkansas for Medical Sciences

Corticosteroids remain my first-line topical treatment for atopic dermatitis due to their availability, cost, and efficacy. Obviously, topical corticosteroids are not an ideal long-term treatment for continuous use due to their cumulative local toxicity. Calcineurin inhibitors are more sustainable i...

How do you time concurrent therapy with rituximab and IVIG?

7
2 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University Hospitals Cleveland Medical Center

Rituximab has about the same half-life as regular IgG. If the regular IVIG treatment can be delayed, it will be less likely to increase the catabolism of Rituximab. If the regular IgG is given at 3-4 week intervals, I would give the Rituxan halfway between IVIG doses. Complement is needed for optima...

Do you perform food challenges after starting Xolair for IgE-mediated food allergy to ensure efficacy?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Scripps Clinic Carmel Valley

I don't do food challenges after starting Xolair for multiple food allergy treatment. Way too cumbersome and I don't see the clinical need as the patient must still avoid the foods.

Does Dupixent interfere with patch testing?

2
1 Answers

Mednet Member
Mednet Member
Dermatology · Case Western Reserve University

Dupilumab suppresses Th2 skewed responses such as those associated with systemic contact dermatitis (e.g. propylene glycol, compositae mix, carmine, etc.) so testing while on dupilumab results in incomplete results. Responses to Th1 skewed allergens (e.g. epoxy or methylchloroisothiazolinone) may be...

Is it necessary to test both english walnut and black walnut when evaluating for a walnut allergy?

1
2 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Rochester Medical Center

English walnuts are the standard grocery store walnut, and are great for everyday baking and snacks. Compared to Black walnut, they are mild, sweet, and buttery. Black walnuts are used in some specialty desserts, but are less commonly used. The two walnuts are greatly cross-reactive, so testing for ...

In a patient with selective IgM deficiency who is completely asymptomatic in terms of infections, what is your typical laboratory work up?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Medical University of South Carolina

B cell phenotyping, lymphocyte subsets, IgG to diphtheria, tetanus and S pneumonia. Evaluate the humoral function, as it is important to know and possibly follow with time, but with an asymptomatic treatment is not warranted.

How do you choose between delgocitinib & ruxolitinib for patients with CHE?

2 Answers

Mednet Member
Mednet Member
Dermatology · Case Western Reserve University

Delgocitinib has broader inhibition (JAKs 1, 2, 3, and TYK2 pathways) compared to ruxolitinib and costs twice as much wholesale price, so I prefer to start with ruxolitinib. I view all dermatitis as some combination of irritant, allergic (Th1 and Th2), and microbial (Th17) factors. CHE usually invol...

How do you manage atopic dermatitis in patients who have failed dupilumab?

2
2 Answers

Mednet Member
Mednet Member
Dermatology · University of California San Diego

The therapeutic landscape for atopic dermatitis is being updated every year, meaning that this question will have different answers in the next few years. In fact, new guidelines are being updated more frequently to capture new drug approvals. As always, medication selection should weigh risks and b...